Cargando…

Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis

Although biologic therapies have changed the course of rheumatoid arthritis (RA), today's major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA....

Descripción completa

Detalles Bibliográficos
Autores principales:	Duroux-Richard, Isabelle, Pers, Yves-Marie, Fabre, Sylvie, Ammari, Meryem, Baeten, Dominique, Cartron, Guillaume, Touitou, Isabelle, Jorgensen, Christian, Apparailly, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980876/ https://www.ncbi.nlm.nih.gov/pubmed/24778468 http://dx.doi.org/10.1155/2014/342524

Ejemplares similares

X-Linked miRNAs Associated with Gender Differences in Rheumatoid Arthritis
por: Khalifa, Olfa, et al.
Publicado: (2016)

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study
por: Gagez, Anne-Laure, et al.
Publicado: (2017)

miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study
por: Duroux-Richard, Isabelle, et al.
Publicado: (2022)

BIK is a novel pro-apoptotic target gene for miR-125b in human monocytes
por: Duroux-Richard, I, et al.
Publicado: (2010)

Mitochondrial MicroRNAs Contribute to Macrophage Immune Functions Including Differentiation, Polarization, and Activation
por: Duroux-Richard, Isabelle, et al.
Publicado: (2021)

TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin
por: Khalifa, Olfa, et al.
Publicado: (2017)

TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
por: Rittore, Cécile, et al.
Publicado: (2021)

MicroRNAs: Fine Tuners of Monocyte Heterogeneity
por: Duroux-Richard, Isabelle, et al.
Publicado: (2019)

Delivery of miR-146a to Ly6C(high) Monocytes Inhibits Pathogenic Bone Erosion in Inflammatory Arthritis
por: Ammari, Meryem, et al.
Publicado: (2018)

MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?
por: Lozano, Claire, et al.
Publicado: (2019)

Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis
por: Nziza, Nadége, et al.
Publicado: (2019)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers
por: Duroux-Richard, Isabelle, et al.
Publicado: (2015)

miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells
por: Pers, Yves-Marie, et al.
Publicado: (2021)

New Vectors and New Targets for Gene Therapy in Rheumatoid Arthritis
por: Jorgensen, C, et al.
Publicado: (2000)

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature
por: Spoerl, David, et al.
Publicado: (2012)

Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient
por: Nogué, Muriel, et al.
Publicado: (2019)

Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence
por: Bade, Pauline, et al.
Publicado: (2021)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Mesenchymal Stromal Cell-Derived Extracellular Vesicles Regulate the Mitochondrial Metabolism via Transfer of miRNAs
por: Loussouarn, Claire, et al.
Publicado: (2021)

Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
por: Bonnet, Isabelle, et al.
Publicado: (2021)

Genetic markers in clinical subtypes of juvenile idiopathic arthritis
por: Le Blay, Pierre, et al.
Publicado: (2011)

Targeted delivery to inflammatory monocytes for efficient RNAi-mediated immuno-intervention in auto-immune arthritis
por: Présumey, Jessy, et al.
Publicado: (2011)

NAMPT/Visfatin expression by inflammatory monocytes mediates arthritis pathogenesis by promoting IL-17–producing T cells
por: Présumey, Jessy, et al.
Publicado: (2012)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023)

Twists and turns of the genetic story of mevalonate kinase-associated diseases: A review
por: Touitou, Isabelle
Publicado: (2021)

Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1
por: Madel, Maria-Bernadette, et al.
Publicado: (2020)

Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis
por: Chen, Guansheng, et al.
Publicado: (2023)

Differential Accumulation and Activation of Monocyte and Dendritic Cell Subsets in Inflamed Synovial Fluid Discriminates Between Juvenile Idiopathic Arthritis and Septic Arthritis
por: Cren, Maïlys, et al.
Publicado: (2020)

Ultrasound assessment of salivary glands in patients with primary Sjögren’s syndrome treated with rituximab: Quantitative and Doppler waveform analysis
por: Jousse-Joulin, Sandrine, et al.
Publicado: (2007)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
por: Bordron, Anne, et al.
Publicado: (2018)

Development of a doxycycline inducible AAV vector for long term in vivo viral IL-10 gene transfer in rheumatoid arthritis
por: Apparailly, F, et al.
Publicado: (2001)

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment
por: Rehnberg, Maria, et al.
Publicado: (2010)

Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases
por: Pers, Yves-Marie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vklm96cnv3b0dnhk62pmkhhqp6